Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2025 491.98M
June 30, 2025 491.75M
March 31, 2025 465.54M
December 31, 2024 465.64M
September 30, 2024 463.80M
June 30, 2024 461.94M
March 31, 2024 448.22M
December 31, 2023 420.27M
September 30, 2023 418.92M
June 30, 2023 396.82M
March 31, 2023 393.41M
December 31, 2022 391.24M
September 30, 2022 399.69M
June 30, 2022 398.70M
March 31, 2022 376.57M
Date Value
December 31, 2021 376.15M
September 30, 2021 365.42M
June 30, 2021 363.42M
March 31, 2021 299.71M
December 31, 2020 276.51M
September 30, 2020 259.72M
June 30, 2020 224.58M
March 31, 2020 216.54M
December 31, 2019 216.53M
September 30, 2019 216.34M
June 30, 2019 215.94M
March 31, 2019 4.880M
December 31, 2018 4.880M
September 30, 2018 4.880M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
cbdMD, Inc. 11.12M
MedMen Enterprises, Inc. --
Australis Capital, Inc. --
ANI Pharmaceuticals, Inc. 22.97M
Corcept Therapeutics, Inc. 107.92M